Congress passes FDA user fee reauthorization bill by October 2026

Makary's departure creates urgency for Congress to pass the FDA's user fee reauthorization bill (PDUFA VII) to avoid funding disruption. The bill has bipartisan support and is typically renewed every 5 years, with a high likelihood of passage before the September 30 deadline.

Implied probability (Yes)

85%